FBInvestor
Stocks / Black Diamond Therapeutics I
Institutional Ownership

Black Diamond Therapeutics I

CUSIP 09203E105COMBDTXQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon